2026 NPPES data Foot & Ankle Surgery Podiatrist NPI 1144483769 DPM
Verify on CMS →

YOKAIRA ESPIRITUSANTO, DPM

Foot & Ankle Surgery Podiatrist in PASSAIC, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 402 beneficiaries · Foot & Ankle Surgery Podiatrist avg: 309
Generic prescribing
97%
generic claims · 3% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$14.49
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

YOKAIRA ESPIRITUSANTO, DPM filed 2,169 Medicare Part D claims in 2023 as a Foot & Ankle Surgery Podiatrist in PASSAIC, New Jersey, prescribing 97% generic.

2K
Part D claims, 2023
97%
generic prescribing
$14.49
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

YOKAIRA ESPIRITUSANTO, DPM's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

2,169 Top 15% higher than 85% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2,000–2,200: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about YOKAIRA ESPIRITUSANTO, DPM?

Quality data not reported

NPI registry status

Active

Issued 07/03/2008

NPI 1144483769

Primary specialty

Foot & Ankle Surgery Podiatrist

Mid-sized

8,920 US NPIs in this specialty

Medicare Part D claims

2,169 602% vs specialty avg

2023 prescription claims

Specialty avg: 309

Specialty distribution in New Jersey

How Foot & Ankle Surgery Podiatrist compares to other specialties among New Jersey providers

New Jersey providers

Foot & Ankle Surgery Podiatrist share within New Jersey

1. Foot & Ankle Surgery Podiatrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Foot & Ankle Surgery Podiatrist share within New Jersey

Specialty board-certification context

Estimated specialty board-certified rate — Foot & Ankle Surgery Podiatrist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Foot & Ankle Surgery Podiatrist ABMS/AOA estimate

Est. board-certified rate (Foot & Ankle Surgery Podiatrist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Foot & Ankle Surgery Podiatrist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

YOKAIRA ESPIRITUSANTO, DPM appears in the CMS NPPES registry as a Foot & Ankle Surgery Podiatrist provider holding DPM credentials at 916 MAIN AVE STE 2A, PASSAIC, NJ, 07055, with a listed phone of (973) 495-3338. NPI 1144483769 was issued on 07/03/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ESPIRITUSANTO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,169 prescription claims written by this provider, covering 402 Medicare beneficiaries and totaling roughly $88K in drug spend, split 3% brand-name and 97% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Foot & Ankle Surgery Podiatrist is a mid-sized specialty nationwide, with 8,920 enrolled providers across 53 states and an average of 309 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

916 MAIN AVE STE 2A
PASSAIC, NJ 07055

Provider Details

NPI 1144483769
Specialty Foot & Ankle Surgery Podiatrist
Credentials DPM
Gender Female
NPI Issued 07/03/2008

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for YOKAIRA ESPIRITUSANTO, DPM. Source: openpaymentsdata.cms.gov.

Total received

$14

Largest payer

Smith+Nephew, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Generic-heavy

YOKAIRA ESPIRITUSANTO, DPM — brand share 3.0%
Specialty average (est.)

3% brand-name claims vs 97% generic, on 2,169 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,169
Total Claims
$88K
Total Drug Cost
402
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,278
Total Day Supply
62,582
Brand vs Generic
3% brand / 97% generic
Brand Drug Cost
$4K
Generic Drug Cost
$84K

Patient Demographics

Average Patient Age
71.3 years
Avg HCC Risk Score
1.61
Gender Split
66% female / 34% male
Age Distribution
<65: 66, 65-74: 189, 75-84: 121, 85+: 26

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What YOKAIRA ESPIRITUSANTO, DPM prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Ciclopirox
497
Diclofenac Sodium
351
Clotrimazole-Betamethasone
Clotrimazole/Betamethasone Dip
350
Ammonium Lactate
313
Clotrimazole
161
Nystatin
96
Nyamyc
Nystatin
61
Silver Sulfadiazine
56
Meloxicam
46

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Foot & Ankle Surgery Podiatrist Overview

How YOKAIRA ESPIRITUSANTO, DPM fits within the Foot & Ankle Surgery Podiatrist landscape nationally.

8,920
Foot & Ankle Surgery Podiatrist Providers in US
53
States with Foot & Ankle Surgery Podiatrist
309
Avg Claims per Provider

YOKAIRA ESPIRITUSANTO, DPM's 2,169 claims are above the specialty average of 309.

Nearby Foot & Ankle Surgery Podiatrist Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as ESPIRITUSANTO.

Compare Foot & Ankle Surgery Podiatrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is YOKAIRA ESPIRITUSANTO, DPM's specialty?
YOKAIRA ESPIRITUSANTO, DPM specializes in Foot & Ankle Surgery Podiatrist and practices in PASSAIC, New Jersey. Credentials: DPM.
How much does YOKAIRA ESPIRITUSANTO, DPM prescribe under Medicare Part D?
In 2023, YOKAIRA ESPIRITUSANTO, DPM wrote 2,169 Medicare Part D claims totaling $88K in drug costs for 402 beneficiaries.
Where is YOKAIRA ESPIRITUSANTO, DPM located?
YOKAIRA ESPIRITUSANTO, DPM is located at 916 MAIN AVE STE 2A, PASSAIC, NJ, 07055. Phone: (973) 495-3338.
What is YOKAIRA ESPIRITUSANTO, DPM's NPI number?
YOKAIRA ESPIRITUSANTO, DPM's National Provider Identifier (NPI) is 1144483769, issued on 07/03/2008.
Does YOKAIRA ESPIRITUSANTO, DPM prescribe more brand-name or generic drugs?
YOKAIRA ESPIRITUSANTO, DPM's prescribing is 3% brand-name and 97% generic drugs by claim count, with $4K in brand drug costs.
How many Foot & Ankle Surgery Podiatrist providers are there in the US?
There are 8,920 Foot & Ankle Surgery Podiatrist providers across 53 states in the US. The average Foot & Ankle Surgery Podiatrist provider writes 309 Medicare Part D claims per year.
What drugs does YOKAIRA ESPIRITUSANTO, DPM prescribe most often?
Based on 2023 Medicare Part D data, YOKAIRA ESPIRITUSANTO, DPM's most frequently prescribed drugs include Ciclopirox, Diclofenac Sodium, Clotrimazole-Betamethasone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does YOKAIRA ESPIRITUSANTO, DPM accept Medicare?
YOKAIRA ESPIRITUSANTO, DPM appears in CMS Medicare data with 2,169 Part D claims and 402 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify YOKAIRA ESPIRITUSANTO, DPM's credentials?
YOKAIRA ESPIRITUSANTO, DPM's NPI is 1144483769 with credentials DPM. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology